How it works
Oxybutynin is a type of medicine called an antimuscarinic (or anticholinergic) muscle relaxant
S
Oxybutynin and tolterodine: FDA approved for the treatment of urge incontinence and detrusor hyperactivity Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis
g
In fact, in 2008 the US product labels for oral oxybutynin were modified to include the potential for anticholinergic CNS events and a warning to monitor patients
Solifenacin Succinate
Patients should be monitored for signs of anticholinergic CNS effects, particularly in the first few months For this reason, avoid driving, operating machinery, or engaging in potentially hazardous activities when starting oxybutynin
5
These symptoms are more likely to occur when you begin taking this medicine, or when the dose is increased
Oxybutynin, also marketed as Ditropan XL, is an anticholinergic medication used for the relief of overactive bladder symptoms that has been optimized for high levels of safety and efficacy since initial FDA approval in 1975
Oral oxybutynin is available as a short-acting tablet and solution that are taken 2 to 4 times a day
5% of anticholinergic medication use
Where the prescribing choice is between oral immediate release oxybutynin or tolterodine, tolterodine might be preferred for reduced risk of dry mouth
Oxybutynin is a tertiary amine that has anticholinergic, spasmolytic, and local anesthetic properties ( Yarker et al 1995 )
A variety of CNS anticholinergic effects have been reported, including hallucinations, agitation, confusion and somnolence
Although not all of these side effects may occur, if they do occur they may need medical attention
" Oxybutynin also directly relaxes the bladder's outer layer of muscle (the detrusor muscle)
Anticholinergic drugs block (antagonize) the action of the neurotransmitter acetylcholine
They are used to treat a wide variety of conditions associated with activation of the parasympathetic nervous system
g
anticholinergic discontinuation syndrome including anxiety, tachycardia, orthostatic hypotension, insomnia)
hallucinations (seeing, hearing, or feeling things that are not there) troubled breathing
Patients should be monitored for signs of anticholinergic CNS effects, particularly in the first few months In fact, in 2008 the US product labels for oral oxybutynin were modified to include the potential for anticholinergic CNS events and a warning to monitor patients for adverse CNS effects